What is an ALT Blood Test?

ALT: A Liver-Cell Enzyme That Leaks When Hepatocytes Are Stressed

Alanine aminotransferase (ALT) is an enzyme kept mainly inside liver cells (hepatocytes). Smaller amounts exist in the kidneys, heart, and skeletal muscle. An ALT blood test measures how much of this normally inside-the-cell enzyme is found in the bloodstream. ALT appears in blood when liver cells release it during routine turnover or when their membranes are stressed. Because the liver is its dominant source, ALT in blood largely reflects signals coming from the liver.

Inside cells, ALT helps the body move fuel between protein and sugar pathways, turning alanine into a key energy-building block (it transfers an amino group from alanine to alpha‑ketoglutarate, forming pyruvate and glutamate). This links protein use to glucose production (gluconeogenesis) and supports nitrogen handling. In practice, measuring ALT in blood offers a direct read on liver cell integrity and metabolic activity, making it a core marker of what is happening inside hepatocytes.

Why ALT Is the Most Liver-Specific Routine Enzyme

Alanine aminotransferase (ALT) is a liver-cell enzyme that leaks into blood when hepatocytes are stressed or injured. Because the liver regulates energy, glucose, lipids, bile, and detoxification, ALT becomes a window into whole‑body metabolism and inflammatory load. It rises when liver cells are stressed or injured, and because the liver governs energy balance, lipid and glucose metabolism, detoxification, and hormone clearance, ALT reflects whole-body metabolic load and cardiometabolic risk.

Reading an ALT Number Across the Range

Most adults fall in the general lab range of about 7–40, with men tending slightly higher than women; children can run a bit higher, and pregnancy often sits similar or slightly lower. For long‑term health, values toward the low-to-mid part of the range are typically seen in metabolically healthy people.

When ALT sits at the low end, it usually reflects a calm liver and lower inflammatory tone. Very low values can accompany low muscle mass, frailty, or vitamin B6 deficiency, and rarely appear in end‑stage liver failure when few hepatocytes remain. Symptoms are uncommon, though fatigue or neuropathy can occur with B6 deficiency. Women and pregnant individuals often show lower normal values without pathology.

Higher ALT points to hepatocellular injury—most often fatty liver related to insulin resistance, alcohol, medications or supplements, viral hepatitis, or ischemia. Exercise can transiently nudge it up. People may feel nothing, or notice fatigue, right‑upper‑abdomen discomfort, nausea, dark urine, itching, or jaundice. In pregnancy, a rise warrants attention because it can signal disorders like preeclampsia/HELLP.

Low values usually reflect lower enzyme activity rather than disease. They occur with low vitamin B6 (pyridoxal phosphate), reduced liver cell mass in advanced cirrhosis, or low muscle mass/frailty; women, older adults, and pregnancy often show lower ALT.

High values usually reflect hepatocellular injury or increased membrane permeability. Common drivers include fatty liver related to insulin resistance, alcohol, viral hepatitis, medications or toxins, and hepatic congestion or ischemia; marked elevations suggest acute injury.

What Can Move ALT Without Liver Disease

Interpretation varies by age, sex, body size, and pregnancy; laboratories use different reference intervals. Recent strenuous exercise and some injections can transiently raise aminotransferases. ALT is more liver-specific than AST, but reading it alongside AST, alkaline phosphatase, and bilirubin clarifies the pattern of liver stress.

Companion Tests That Localize Liver Stress

ALT integrates hepatic integrity with metabolic health. Interpreting it alongside AST, GGT, alkaline phosphatase, bilirubin, albumin, and coagulation tests—and watching trends—helps gauge fibrosis risk, cardiometabolic burden, and long‑term outcomes. Elevated ALT correlates with higher risk of metabolic syndrome and cardiovascular disease; during pregnancy, hypertensive or cholestatic disorders can raise ALT.

What Tracking ALT Over Time Reveals

Being in range suggests intact hepatocyte membranes and balanced gluconeogenesis, consistent with stable metabolic and inflammatory tone. Within the reference interval, risk signals tend to be lowest toward the lower end, not at zero. ALT trends—not a single reading—best gauge liver health and long-term cardiometabolic burden.